Skip to main content

Table 7 Degree of agreement between HCV RNA and HCVcAg results at the 12th and 24th week among the studied groups

From: Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

HCV RNA at the 12th week Total
  Positive Negative
HCVcAg at the 12th week Positive No. 10 0 10
% (within HCV RNA at the 12th week) 100.0 .0 3.6
Negative No. 0 270 270
% (within HCV RNA 12th week) .0 100.0 96.4
Total No. 10 270 280
% (within HCV RNA 12th week) 100.0 100.0 100.0
HCV RNA at the 24th week Total
  Positive Negative
HCVcAg at the 24th week Positive No. 20 0 20
% (within HCV RNA at the 24th week) 100.0 .0 7.1
Negative No. 0 260 260
% (within HCV RNA at the 24th week) .0 100.0 92.9
Total No. 20 260 280
% (within HCV RNA at the 24th week) 100.0 100.0 100.0